Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. - Henderson,I.C.; Berry,D.A.; Demetri,G.D. (J Clin Oncol, 2003)